Vitreous administration of erythropoietin

Details Vitreous administration of erythropoietin Vitreous administration of erythropoietin

A - Human Necessities

61

K

A61K 38/18 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2650877

A therapeutic composition for treating and/or preventing retinal disorder includes intravitreally or transsclerally administered erythropoietin.

L'invention concerne une composition thérapeutique destinée au traitement et/ou à la prévention d'un trouble rétinien, consistant à administrer de l'érythropoïétine par voie intravitréenne ou transsclérale.

Affiliated with

Also associated with

Rating

Vitreous administration of erythropoietin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vitreous administration of erythropoietin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitreous administration of erythropoietin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1721208